Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options

Antiviral Research

Volumn 122, Issue , 2015, Pages 112-129

  Alfaiate, Dulce ^a,b   Dény, Paul ^a,c   Durantel, David ^a,b,d  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d LabEx DEVweCAN   (France)

Author keywords

HBV HDV co infections; Hepatitis D virus; Interferon alpha; Pathogenesis; Viral interference

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CYCLOSPORIN A; EZETIMIBE; HEPATITIS B ANTIGEN; HEPATITIS B VACCINE; HOST FACTOR; IRBESARTAN; PEGINTERFERON ALPHA; RIBONUCLEOPROTEIN; RIBOZYME; RITONAVIR; TENOFOVIR; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL THERAPY; CLINICAL FEATURE; DELTA AGENT HEPATITIS; DISEASE COURSE; ENDEMIC DISEASE; EXPERIMENTAL THERAPY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; LIFE CYCLE; LIVER CARCINOGENESIS; LIVER DISEASE; LIVER FIBROSIS; MEDICAL HISTORY; MIXED INFECTION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SUPERINFECTION; VIRUS ASSEMBLY; VIRUS ATTACHMENT; VIRUS DETECTION; VIRUS ENTRY; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION; VIRUS UNCOATING; COINFECTION; COMPLICATION; DRUG EFFECTS; HEPATITIS D, CHRONIC; LIVER CELL CARCINOMA; LIVER NEOPLASMS; PHYSIOLOGY; VIROLOGY; VIRUS INTERFERENCE;

HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS;

ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; COINFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; LIVER NEOPLASMS; MOLECULAR EPIDEMIOLOGY; VIRAL INTERFERENCE; VIRUS ASSEMBLY; VIRUS RELEASE; VIRUS REPLICATION;

EID: 84940193272     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.08.009     Document Type: Review

References (236)

1. D. Alfaiate, N.A. Abeywickrama-Samarakoon, B. Testoni, J. Lucifora, F. Zoulim, J.-C. Cortay, and et al. Model of HBV/HDV super-infection to study mechanisms of viral interplay and antivirals Hepatology 60 Special issue 2014 1038A
2. M.V. Alvarado-Mora, and J.R.R. Pinho Epidemiological update of hepatitis B, C and delta in Latin America Antivir. Ther. 18 2013 429 433
3. C. Alves, H. Cheng, H. Roder, and J. Taylor Intrinsic disorder and oligomerization of the hepatitis delta virus antigen Virology 407 2010 333 340
4. I.E. Andernach, L.V. Leiss, Z.S. Tarnagda, M.C. Tahita, J.A. Otegbayo, J.C. Forbi, and et al. Characterization of hepatitis delta virus in sub-Saharan Africa J. Clin. Microbiol. 52 2014 1629 1636
5. N. Aslan, C. Yurdaydin, J. Wiegand, T. Greten, A. Ciner, M.F. Meyer, and et al. Cytotoxic CD4 T cells in viral hepatitis J. Viral Hepat. 13 2006 505 514
6. A. Barrera, B. Guerra, H. Lee, and R.E. Lanford Analysis of host range phenotypes of primate hepadnaviruses by in vitro infections of hepatitis D virus pseudotypes J. Virol. 78 2004 5233 5243
7. Y. Beeharry, L. Rocheleau, and M. Pelchat Conserved features of an RNA promoter for RNA polymerase II determined from sequence heterogeneity of a hepatitis delta virus population Virology 450-451 2014 165 173
8. G. Bensabath, S.C. Hadler, M.C. Soares, H. Fields, L.B. Dias, H. Popper, and et al. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin JAMA 258 1987 479 483
9. V.V. Bichko, Y.E. Khudyakov, and J.M. Taylor A novel form of hepatitis delta antigen J. Virol. 70 1996 3248 3251
10. V.V. Bichko, S.M. Lemon, J.G. Wang, S. Hwang, M.M. Lai, and J.M. Taylor Epitopes exposed on hepatitis delta virus ribonucleoproteins J. Virol. 70 1996 5807 5811
11. M.T. Bility, L. Cheng, Z. Zhang, Y. Luan, F. Li, L. Chi, and et al. Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages PLoS Pathog. 10 2014 e1004032
12. K.-D. Bissig, S.F. Wieland, P. Tran, M. Isogawa, T.T. Le, F.V. Chisari, and et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment J. Clin. Invest. 120 2010 924 930
13. M. Blanchet, and C. Sureau Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues J. Virol. 81 2007 5841 5849
14. M. Blanchet, C. Sureau, and P. Labonté Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle Antivir. Res. 106 2014 111 115
15. P. Bogomolov, N. Voronkova, L. Allweiss, M. Dandri, M. Schwab, F.A. Lempp, and et al. A proof-of-concept Phase 2a clinical trial with HBV/HDV entry inhibitor Myrcludex B Hepatology 60 2014 1279A 1280A
16. B.B. Bordier, J. Ohkanda, P. Liu, S.-Y. Lee, F.H. Salazar, P.L. Marion, and et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus J. Clin. Invest. 112 2003 407 414
17. B.B. Bordier, P.L. Marion, K. Ohashi, M.A. Kay, H.B. Greenberg, J.L. Casey, and et al. A prenylation inhibitor prevents production of infectious hepatitis delta virus particles J. Virol. 76 2002 10465 10472
18. A. Boyd, P. Miailhes, S. Brichler, C. Scholtès, S. Maylin, C. Delaugerre, and et al. Effect of tenofovir with and without interferon on hepatitis D virus replication in HIV-hepatitis B virus-hepatitis D virus-infected patients AIDS Res. Hum. Retrovir. 29 2013 1535 1540
19. W.S.M. Braga, Castilho M. da C, F.G. Borges, J.R.D.T. Leão, Martinho A.C. de S, I.S. Rodrigues, and et al. Hepatitis D virus infection in the Western Brazilian Amazon - far from a vanishing disease Rev. Soc. Bras. Med. Trop. 45 2012 691 695
20. W.S.M. Braga, C.M.C. de Oliveira, J.R. de Araújo, Castilho M. da C, J.M. Rocha, Gimaque J.B. de L, and et al. Chronic HDV/HBV co-infection: predictors of disease stage - a case series of HDV-3 patients J. Hepatol. 61 2014 1205 1211
21. R. Brazas, and D. Ganem A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution Science 274 1996 90 94
22. S. Brichler, F. Le Gal, A. Butt, S. Chevret, and E. Gordien Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia Clin. Gastroenterol. Hepatol. 11 2013 734 740
23. M.G. Brook Sexual transmission and prevention of the hepatitis viruses A-E and G Sex Transm. Infect. 74 1998 395 398
24. M. Buti, M. Homs, F. Rodriguez-Frias, G. Funalleras, R. Jardí, S. Sauleda, and et al. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study J. Viral Hepat. 18 2011 434 442
25. B. Calle Serrano, A. Großhennig, M. Homs, B. Heidrich, A. Erhardt, K. Deterding, and et al. Development and evaluation of a baseline-event-anticipation score for hepatitis delta J. Viral Hepat. 21 2014 e154 e163
26. D. Cao, D. Haussecker, Y. Huang, and M.A. Kay Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication RNA 15 2009 1971 1979
27. F. Caredda, E. Rossi, A. d'Arminio Monforte, L. Zampini, T. Re, B. Meroni, and et al. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome J. Infect. Dis. 151 1985 925 928
28. J.L. Casey Control of ADAR1 editing of hepatitis delta virus RNAs Curr. Top. Microbiol. Immunol. 353 2012 123 143
29. J.L. Casey, G.A. Niro, R.E. Engle, A. Vega, H. Gomez, M. McCarthy, and et al. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F J. Infect. Dis. 174 1996 920 926
30. C. Castellares, P. Barreiro, L. Martín-Carbonero, P. Labarga, M.E. Vispo, R. Casado, and et al. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome J. Viral Hepat. 15 2008 165 172
31. J. Chang, and J. Taylor In vivo RNA-directed transcription, with template switching, by a mammalian RNA polymerase EMBO J. 21 2002 157 164
32. F.L. Chang, P.J. Chen, S.J. Tu, C.J. Wang, and D.S. Chen The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus Proc. Natl. Acad. Sci. U.S.A. 88 1991 8490 8494
33. J. Chang, L.J. Sigal, A. Lerro, and J. Taylor Replication of the human hepatitis delta virus genome is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences J. Virol. 75 2001 3469 3473
34. J. Chang, S.O. Gudima, C. Tarn, X. Nie, and J.M. Taylor Development of a novel system to study hepatitis delta virus genome replication J. Virol. 79 2005 8182 8188
35. J. Chang, X. Nie, H.E. Chang, Z. Han, and J. Taylor Transcription of hepatitis delta virus RNA by RNA polymerase II J. Virol. 82 2008 1118 1127
36. S.-Y. Chang, C.-L. Yang, W.-S. Ko, W.-C. Liu, C.-Y. Lin, C.-H. Wu, and et al. Molecular epidemiology of hepatitis D virus infection among injecting drug users with and without human immunodeficiency virus infection in Taiwan J. Clin. Microbiol. 49 2011 1083 1089
37. J. Chang, S.O. Gudima, and J.M. Taylor Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture J. Virol. 79 2005 13310 13316
38. M. Chao RNA recombination in hepatitis delta virus: implications regarding the abilities of mammalian RNA polymerases Virus Res. 127 2007 208 215
39. M. Chao, S.Y. Hsieh, and J. Taylor Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication J. Virol. 64 1990 5066 5069
40. Y.C. Chao, H.S. Tang, and C.T. Hsu Evolution rate of hepatitis delta virus RNA isolated in Taiwan J. Med. Virol. 43 1994 397 403
41. P.J. Chen, G. Kalpana, J. Goldberg, W. Mason, B. Werner, J. Gerin, and et al. Structure and replication of the genome of the hepatitis delta virus Proc. Natl. Acad. Sci. U.S.A. 83 1986 8774 8778
42. S.-H. Choi, S.-H. Jeong, and S.B. Hwang Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis Gastroenterology 132 2007 343 357
43. H.C. Chou, T.Y. Hsieh, G.T. Sheu, and M.M. Lai Hepatitis delta antigen mediates the nuclear import of hepatitis delta virus RNA J. Virol. 72 1998 3684 3690
44. Chudy M., Hanschmann K.-M., Bozdayi M., Kreß J., Nübling M., WHO Expert Committee on Biological Standardization (2013: Geneva S, et al. Collaborative study to establish a World Health Organization international standard for hepatitis D virus RNA for nucleic acid amplification technique (NAT)-based assays. 2013 [cité 28 févr 2015]. Available from: http://apps.who.int//iris/handle/10665/96341.
45. A. Ciancio, and M. Rizzetto Chronic hepatitis D at a standstill: where do we go from here? Nat. Rev. Gastroenterol. Hepatol. 11 2014 68 71
46. M.A.E. Crispim, N.A. Fraiji, S.C. Campello, N.A. Schriefer, M.M.A. Stefani, and D. Kiesslich Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the Western Amazon region, North Brazil BMC Infect. Dis. 14 2014 94
47. T.J.S. Cross, P. Rizzi, M. Horner, A. Jolly, M.J. Hussain, H.M. Smith, and et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London J. Med. Virol. 80 2008 277 282
48. M. Dandri, and M. Lütgehetmann Mouse models of hepatitis B and delta virus infection J. Immunol. Methods 410 2014 39 49
49. M. Dandri, M.R. Burda, E. Török, J.M. Pollok, A. Iwanska, G. Sommer, and et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus Hepatology 33 2001 981 988
50. P. Dény Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr. Top. Microbiol. Immunol. 307 2006 151 171
51. J.F. Drexler, A. Geipel, A. König, V.M. Corman, D. van Riel, L.M. Leijten, and et al. Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes Proc. Natl. Acad. Sci. U.S.A. 110 2013 16151 16156
52. European Association for the Study of the Liver EASL clinical practice guidelines: Management of chronic hepatitis B virus infection J. Hepatol. 57 2012 167 185
53. P. Farci, and G.A. Niro Clinical features of hepatitis D Semin. Liver Dis. 32 2012 228 236
54. G. Fattovich, S. Boscaro, F. Noventa, E. Pornaro, D. Stenico, A. Alberti, and et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B J. Infect. Dis. 155 1987 931 935
55. G. Fattovich, G. Giustina, E. Christensen, M. Pantalena, I. Zagni, G. Realdi, and et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep) Gut 46 2000 420 426
56. R.B. Ferns, E. Nastouli, and J.A. Garson Quantitation of hepatitis delta virus using a single-step internally controlled real-time RT-qPCR and a full-length genomic RNA calibration standard J. Virol. Methods 179 2012 189 194
57. M. Fiedler, M. Lu, F. Siegel, J. Whipple, and M. Roggendorf Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine Vaccine 19 2001 4618 4626
58. M. Fiedler, A. Kosinska, A. Schumann, O. Brovko, A. Walker, M. Lu, and et al. Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus J. Virol. 87 2013 7708 7716
59. E. Flodgren, S. Bengtsson, M. Knutsson, E.A. Strebkova, A.H. Kidd, O.A. Alexeyev, and et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains J. Clin. Microbiol. 38 2000 3311 3316
60. R. Flores, S. Ruiz-Ruiz, and P. Serra Viroids and hepatitis delta virus Semin. Liver Dis. 32 2012 201 210
61. N. Freitas, K. Abe, C. Cunha, S. Menne, and S.O. Gudima Support of the infectivity of hepatitis delta virus particles by the envelope proteins of different genotypes of hepatitis B virus J. Virol. 88 2014 6255 6267
62. F.J. Galizzi, R. Teixeira, J.C.F. Fonseca, and F.J.D. Souto Clinical profile of hepatitis B virus chronic infection in patients of Brazilian liver reference units Hepatol. Int. 4 2010 511 515
63. K. Giersch, M. Helbig, T. Volz, L. Allweiss, L.V. Mancke, A.W. Lohse, and et al. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection J. Hepatol. 60 2014 538 544
64. K. Giersch, L. Allweiss, T. Volz, M. Helbig, J. Bierwolf, A.W. Lohse, and et al. Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection J. Hepatol. 2015
65. R.G. Gish, D.H. Yi, S. Kane, M. Clark, M. Mangahas, S. Baqai, and et al. Coinfection with hepatitis B and D: Epidemiology, prevalence and disease in patients in Northern California J. Gastroenterol. Hepatol. 28 2013 1521 1525
66. J.S. Glenn, J.A. Watson, C.M. Havel, and J.M. White Identification of a prenylation site in delta virus large antigen Science 256 1992 1331 1333
67. T. Goto, N. Kato, H. Yoshida, M. Otsuka, M. Moriyama, Y. Shiratori, and et al. Synergistic activation of the serum response element-dependent pathway by hepatitis B virus x protein and large-isoform hepatitis delta antigen J. Infect. Dis. 187 2003 820 828
68. A. Goyal, and J.M. Murray Effect of interferon-alfa therapy on hepatitis D virus Hepatology 61 2015 2117 2118
69. J. Grabowski, C. Yurdaydìn, K. Zachou, P. Buggisch, W.P. Hofmann, J. Jaroszewicz, and et al. Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment Liver Int. 31 2011 1395 1405
70. V. Greco-Stewart, and M. Pelchat Interaction of host cellular proteins with components of the hepatitis delta virus Viruses 2 2010 189 212
71. V.S. Greco-Stewart, P. Miron, A. Abrahem, and M. Pelchat The human RNA polymerase II interacts with the terminal stem-loop regions of the hepatitis delta virus RNA genome Virology 357 2007 68 78
72. V.S. Greco-Stewart, E. Schissel, and M. Pelchat The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III Virology 386 2009 12 15
73. B.L. Griffin, S. Chasovskikh, A. Dritschilo, and J.L. Casey Hepatitis delta antigen requires a flexible quasi-double-stranded RNA structure to bind and condense hepatitis delta virus RNA in a ribonucleoprotein complex J. Virol. 88 2014 7402 7411
74. P. Gripon, J. Le Seyec, S. Rumin, and C. Guguen-Guillouzo Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity Virology 213 1995 292 299
75. P. Gripon, I. Cannie, and S. Urban Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein J. Virol. 79 2005 1613 1622
76. P. Grippon, O. Ribiere, J.F. Cadranel, S. Pelletier, B. Pillot, J. Emerit, and et al. Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients Lancet 1 1987 1031
77. S. Gudima, S.Y. Wu, C.M. Chiang, G. Moraleda, and J. Taylor Origin of hepatitis delta virus mRNA J. Virol. 74 2000 7204 7210
78. S. Gudima, J. Chang, G. Moraleda, A. Azvolinsky, and J. Taylor Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA J. Virol. 76 2002 3709 3719
79. S.O. Gudima, J. Chang, and J.M. Taylor Reconstitution in cultured cells of replicating HDV RNA from pairs of less than full-length RNAs RNA 11 2005 90 98
80. S. Gudima, Y. He, A. Meier, J. Chang, R. Chen, M. Jarnik, and et al. Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes J. Virol. 81 2007 3608 3617
81. S. Guilhot, S.N. Huang, Y.P. Xia, N. La Monica, M.M. Lai, and F.V. Chisari Expression of the hepatitis delta virus large and small antigens in transgenic mice J. Virol. 68 1994 1052 1058
82. T.L. Gutti, J.S. Knibbe, E. Makarov, J. Zhang, G.R. Yannam, S. Gorantla, and et al. Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice Am. J. Pathol. 184 2014 101 109
83. S.J. Hadziyannis, M. Sherman, H.M. Lieberman, and D.A. Shafritz Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers Hepatology 5 1985 544 547
84. Z. Han, S. Nogusa, E. Nicolas, S. Balachandran, and J. Taylor Interferon impedes an early step of hepatitis delta virus infection PLoS One 6 2011 e22415
85. M. Han, M. Littlejohn, L. Yuen, R. Edwards, U. Devi, S. Bowden, and et al. Molecular epidemiology of hepatitis delta virus in the Western Pacific region J. Clin. Virol. 61 2014 34 39
86. D. Hartwig, C. Schütte, J. Warnecke, I. Dorn, H. Hennig, H. Kirchner, and et al. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells J. Viral Hepat. 13 2006 150 157
87. D. Hartwig, L. Schoeneich, J. Greeve, C. Schütte, I. Dorn, H. Kirchner, and et al. Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection J. Hepatol. 41 2004 667 672
88. W. He, B. Ren, F. Mao, Z. Jing, Y. Li, Y. Liu, and et al. Hepatitis D virus infection of mice expressing human sodium taurocholate co-transporting polypeptide PLoS Pathog. 11 2015 e1004840
89. B. Heidrich, C. YurdaydIn, G. Kabaçam, B.A. Ratsch, K. Zachou, B. Bremer, and et al. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta Hepatology 60 2014 87 97
90. L.A. Heinicke, and P.C. Bevilacqua Activation of PKR by RNA misfolding: HDV ribozyme dimers activate PKR RNA 18 2012 2157 2165
91. M. Homs, K. Giersch, M. Blasi, M. Lütgehetmann, M. Buti, R. Esteban, and et al. Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification J. Clin. Microbiol. 52 2014 3334 3338
92. S.Y. Hsieh, M. Chao, L. Coates, and J. Taylor Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen J. Virol. 64 1990 3192 3198
93. W.H. Huang, B.Y. Yung, W.J. Syu, and Y.H. Lee The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication J. Biol. Chem. 276 2001 25166 25175
94. I.-C. Huang, C.-Y. Chien, C.-R. Huang, and S.J. Lo Induction of hepatitis D virus large antigen translocation to the cytoplasm by hepatitis B virus surface antigens correlates with endoplasmic reticulum stress and NF-kappaB activation J. Gen. Virol. 87 2006 1715 1723
95. C. Huang, S.C. Chang, I.-C. Yu, Y.-G. Tsay, and M.-F. Chang Large hepatitis delta antigen is a novel clathrin adaptor-like protein J. Virol. 81 2007 5985 5994
96. C. Huang, S.C. Chang, H.-C. Yang, C.-L. Chien, and M.-F. Chang Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus J. Virol. 83 2009 12314 12324
97. H.-C. Huang, C.-C. Chen, W.-C. Chang, M.-H. Tao, and C. Huang Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis J. Virol. 86 2012 9443 9453
98. Y.-H. Huang, M.-H. Tao, C. Hu, W.-J. Syu, and J.-C. Wu Identification of novel HLA-A∗0201-restricted CD8+ T-cell epitopes on hepatitis delta virus J. Gen. Virol. 85 2004 3089 3098
99. S.A. Hughes, H. Wedemeyer, and P.M. Harrison Hepatitis delta virus Lancet 378 2011 73 85
100. S.B. Hwang, and M.M. Lai Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen J. Virol. 67 1993 7659 7662
101. G.M. Jenkins, A. Rambaut, O.G. Pybus, and E.C. Holmes Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis J. Mol. Evol. 54 2002 156 165
102. J. Ji, K. Sundquist, and J. Sundquist A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma J. Natl Cancer Inst. 104 2012 790 792
103. R. Julithe, G. Abou-Jaoudé, and C. Sureau Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies J. Virol. 88 2014 9049 9059
104. C. Koh, L. Canini, H. Dahari, X. Zhao, S.L. Uprichard, V. Haynes-Williams, and et al. Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial Lancet Infect. Dis. 2015
105. K. Kosaka, N. Hiraga, M. Imamura, S. Yoshimi, E. Murakami, T. Nakahara, and et al. A novel TK-NOG based humanized mouse model for the study of HBV and HCV infections Biochem. Biophys. Res. Commun. 441 2013 230 235
106. M. Krepstakies, J. Lucifora, C.-H. Nagel, M.B. Zeisel, B. Holstermann, H. Hohenberg, and et al. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses J. Infect. Dis. 205 2012 1654 1664
107. M.Y. Kuo, J. Goldberg, L. Coates, W. Mason, J. Gerin, and J. Taylor Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications J. Virol. 62 1988 1855 1861
108. M.Y. Kuo, L. Sharmeen, G. Dinter-Gottlieb, and J. Taylor Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus J. Virol. 62 1988 4439 4444
109. M.Y. Kuo, M. Chao, and J. Taylor Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen J. Virol. 63 1989 1945 1950
110. M.M.C. Lai RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus J. Virol. 79 2005 7951 7958
111. O. Lamas Longarela, T.T. Schmidt, K. Schöneweis, R. Romeo, H. Wedemeyer, S. Urban, and et al. Proteoglycans act as cellular hepatitis delta virus attachment receptors PLoS One 8 2013 e58340
112. R.E. Lanford, B. Guerra, D. Chavez, L. Giavedoni, V.L. Hodara, K.M. Brasky, and et al. GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees Gastroenterology 144 2013 1508 1517 1517.e1-10
113. Y. Le Duff, M. Blanchet, and C. Sureau The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent J. Virol. 83 2009 12443 12451
114. F. Le Gal, E. Gordien, D. Affolabi, T. Hanslik, C. Alloui, P. Dény, and et al. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients J. Clin. Microbiol. 43 2005 2363 2369
115. F. Le Gal, E. Gault, M.-P. Ripault, J. Serpaggi, J.-C. Trinchet, E. Gordien, and et al. Eighth major clade for hepatitis delta virus Emerg. Infect. Dis. 12 2006 1447 1450
116. F. Le Gal, C. Castelneau, E. Gault, N. Hawajri, E. Gordien, P. Marcellin, and et al. Hepatology 45 2007 1332 1333
117. C.M. Lee, F.Y. Bih, Y.C. Chao, S. Govindarajan, and M.M. Lai Evolution of hepatitis delta virus RNA during chronic infection Virology 188 1992 265 273
118. C.H. Lee, S.C. Chang, C.H. Wu, and M.F. Chang A novel chromosome region maintenance 1-independent nuclear export signal of the large form of hepatitis delta antigen that is required for the viral assembly J. Biol. Chem. 276 2001 8142 8148
119. C.M. Leistner, S. Gruen-Bernhard, and D. Glebe Role of glycosaminoglycans for binding and infection of hepatitis B virus Cell Microbiol. 10 2008 122 133
120. Y.-J. Li, T. Macnaughton, L. Gao, and M.M.C. Lai RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies J. Virol. 80 2006 6478 6486
121. F.-T. Liao, Y.-J. Lee, J.-L. Ko, C.-C. Tsai, C.-J. Tseng, and G.-T. Sheu Hepatitis delta virus epigenetically enhances clusterin expression via histone acetylation in human hepatocellular carcinoma cells J. Gen. Virol. 90 2009 1124 1134
122. B.C. Lin, D.A. Defenbaugh, and J.L. Casey Multimerization of hepatitis delta antigen is a critical determinant of RNA binding specificity J. Virol. 84 2010 1406 1413
123. Y.T. Liu, R. Brazas, and D. Ganem Efficient hepatitis delta virus RNA replication in avian cells requires a permissive factor(s) from mammalian cells J. Virol. 75 2001 7489 7493
124. K. Lo, S.B. Hwang, R. Duncan, M. Trousdale, and M.M. Lai Characterization of mRNA for hepatitis delta antigen: exclusion of the full-length antigenomic RNA as an mRNA Virology 250 1998 94 105
125. A.S.F. Lok, and B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
126. M. Long, S.J. de Souza, and W. Gilbert Delta-interacting protein A and the origin of hepatitis delta antigen Science 276 1997 824 825
127. F. Lunel-Fabiani, W. Mansour, A.O. Amar, M. Aye, F. Le Gal, F.-Z.F. Malick, and et al. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study J. Infect. 67 2013 448 457
128. S. Lunemann, D.F.G. Malone, J. Hengst, K. Port, J. Grabowski, K. Deterding, and et al. Compromised function of natural killer cells in acute and chronic viral hepatitis J. Infect. Dis. 209 2014 1362 1373
129. M. Lütgehetmann, L.V. Mancke, T. Volz, M. Helbig, L. Allweiss, T. Bornscheuer, and et al. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation Hepatology 55 2012 685 694
130. T.B. Macnaughton, and M.M.C. Lai Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing J. Virol. 76 2002 3928 3935
131. A. Macovei, C. Petrareanu, C. Lazar, P. Florian, and N. Branza-Nichita Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment J. Virol. 87 2013 6415 6427
132. M. Makuwa, A. Mintsa-Ndong, S. Souquière, D. Nkoghé, E.M. Leroy, and M. Kazanji Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa J. Clin. Microbiol. 47 2009 2265 2268
133. A.N. McNair, D. Cheng, J. Monjardino, H.C. Thomas, and I.M. Kerr Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA J. Gen. Virol. 75 1994 1371 1378
134. I. Mederacke, B. Bremer, B. Heidrich, J. Kirschner, K. Deterding, T. Bock, and et al. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics J. Clin. Microbiol. 48 2010 2022 2029
135. M. Mendes, D. Pérez-Hernandez, J. Vázquez, A.V. Coelho, and C. Cunha Proteomic changes in HEK-293 cells induced by hepatitis delta virus replication J. Proteomics 89 2013 24 38
136. S. Menne, D.B. Tumas, K.H. Liu, L. Thampi, D. AlDeghaither, B.H. Baldwin, and et al. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B J. Hepatol. 62 2015 1237 1245
137. L.E. Modahl, and M.M. Lai The large delta antigen of hepatitis delta virus potently inhibits genomic but not antigenomic RNA synthesis: a mechanism enabling initiation of viral replication J. Virol. 74 2000 7375 7380
138. L.E. Modahl, T.B. Macnaughton, N. Zhu, D.L. Johnson, and M.M. Lai RNA-dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases Mol. Cell. Biol. 20 2000 6030 6039
139. T. Moestrup, B.G. Hansson, A. Widell, and E. Nordenfelt Clinical aspects of delta infection Br. Med. J. Clin. Res. Ed. 286 1983 87 90
140. S. Mota, M. Mendes, D. Penque, A.V. Coelho, and C. Cunha Changes in the proteome of Huh7 cells induced by transient expression of hepatitis D virus RNA and antigens J. Proteomics 71 2008 71 79
141. S. Mota, M. Mendes, N. Freitas, D. Penque, A.V. Coelho, and C. Cunha Proteome analysis of a human liver carcinoma cell line stably expressing hepatitis delta virus ribonucleoproteins J. Proteomics 72 2009 616 627
142. F. Negro, B.E. Korba, B. Forzani, B.M. Baroudy, T.L. Brown, J.L. Gerin, and et al. Hepatitis delta virus (HDV) and woodchuck hepatitis virus (WHV) nucleic acids in tissues of HDV-infected chronic WHV carrier woodchucks J. Virol. 63 1989 1612 1618
143. H.J. Netter, K. Kajino, and J.M. Taylor Experimental transmission of human hepatitis delta virus to the laboratory mouse J. Virol. 67 1993 3357 3362
144. G.A. Niro, J.L. Casey, E. Gravinese, M. Garrubba, P. Conoscitore, E. Sagnelli, and et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence J. Hepatol. 30 1999 564 569
145. G.A. Niro, F. Rosina, and M. Rizzetto Treatment of hepatitis D J. Viral Hepatol. 12 2005 2 9
146. G.A. Niro, A. Smedile, A.M. Ippolito, A. Ciancio, R. Fontana, A. Olivero, and et al. Outcome of chronic delta hepatitis in Italy: a long-term cohort study J. Hepatol. 53 2010 834 840
147. R. Nisini, M. Paroli, D. Accapezzato, F. Bonino, F. Rosina, T. Santantonio, and et al. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles J. Virol. 71 1997 2241 2251
148. S. Nkongolo, Y. Ni, F.A. Lempp, C. Kaufman, T. Lindner, K. Esser-Nobis, and et al. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor J. Hepatol. 60 2014 723 731
149. F. Noordeen, A. Vaillant, and A.R. Jilbert Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro Antimicrob. Agents Chemother. 57 2013 5291 5298
150. F. Noordeen, A. Vaillant, and A.R. Jilbert Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo Antimicrob. Agents Chemother. 57 2013 5299 5306
151. M. Noureddin, and R. Gish Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery Curr. Gastroenterol. Rep. 16 2014 365
152. A. Olivero, and A. Smedile Hepatitis delta virus diagnosis Semin. Liver Dis. 32 2012 220 227
153. N. Ormeci, F. Bölükbaş, E. Erden, S. Coban, F. Ekiz, H. Erdem, and et al. Pegylated interferon alfa-2B for chronic delta hepatitis: 12 versus 24 months Hepatogastroenterology 58 2011 1648 1653
154. A. Ottobrelli, A. Marzano, A. Smedile, S. Recchia, M. Salizzoni, C. Cornu, and et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation Gastroenterology 101 1991 1649 1655
155. T. Oyunsuren, F. Kurbanov, Y. Tanaka, A. Elkady, R. Sanduijav, O. Khajidsuren, and et al. High frequency of hepatocellular carcinoma in Mongolia; association with mono-, or co-infection with hepatitis C, B, and delta viruses J. Med. Virol. 78 2006 1688 1695
156. A. Pár, S. Luminita, I. Erdósy, D. Doru, I. Kádas, M. Paál, and et al. Hepatitis virus (HBV, HCV, HDV) markers in chronic liver diseases. Comparative studies in two East-Central European countries Orv. Hetil. 133 1992 48 50
157. C.-Y. Park, S.-H. Oh, S.M. Kang, Y.-S. Lim, and S.B. Hwang Hepatitis delta virus large antigen sensitizes to TNF-alpha-induced NF-kappaB signaling Mol. Cells 28 2009 49 55
158. T. Pollicino, G. Raffa, T. Santantonio, G.B. Gaeta, G. Iannello, A. Alibrandi, and et al. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses J. Virol. 85 2011 432 439
159. J.M. Polo, K.S. Jeng, B. Lim, S. Govindarajan, F. Hofman, F. Sangiorgi, and et al. Transgenic mice support replication of hepatitis delta virus RNA in multiple tissues, particularly in skeletal muscle J. Virol. 69 1995 4880 4887
160. A.G. Polson, B.L. Bass, and J.L. Casey RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase Nature 380 1996 454 456
161. A. Ponzetto, P.J. Cote, H. Popper, B.H. Hoyer, W.T. London, E.C. Ford, and et al. Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck Proc. Natl. Acad. Sci. U.S.A. 81 1984 2208 2212
162. A. Ponzetto, B. Forzani, P.P. Parravicini, C. Hele, A. Zanetti, and M. Rizzetto Epidemiology of hepatitis delta virus (HDV) infection Eur. J. Epidemiol. 1 1985 257 263
163. P. Pugnale, V. Pazienza, K. Guilloux, and F. Negro Hepatitis delta virus inhibits alpha interferon signaling Hepatology 49 2009 398 406
164. N. Radjef, E. Gordien, V. Ivaniushina, E. Gault, P. Anaïs, T. Drugan, and et al. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades J. Virol. 78 2004 2537 2544
165. C.E. Reid, and D.W. Lazinski A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs Proc. Natl. Acad. Sci. U.S.A. 97 2000 424 429
166. C. Reinheimer, H.W. Doerr, and A. Berger Hepatitis delta: on soft paws across Germany Infection 40 2012 621 625
167. N. Riccitelli, and A. Lupták HDV family of self-cleaving ribozymes Prog. Mol. Biol. Transl. Sci. 120 2013 123 171
168. M. Rizzetto, and A. Ciancio Epidemiology of hepatitis D Semin. Liver Dis. 32 2012 211 219
169. M. Rizzetto, M.G. Canese, S. Aricò, O. Crivelli, C. Trepo, F. Bonino, and et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers Gut 18 1977 997 1003
170. M. Rizzetto, J.W. Shih, D.J. Gocke, R.H. Purcell, G. Verme, and J.L. Gerin Incidence and significance of antibodies to delta antigen in hepatitis B virus infection Lancet 2 1979 986 990
171. M. Rizzetto, R.H. Purcell, and J.L. Gerin Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers Lancet 1 1980 1215 1218
172. M. Rizzetto, M.G. Canese, J.L. Gerin, W.T. London, D.L. Sly, and R.H. Purcell Transmission of the hepatitis B virus-associated delta antigen to chimpanzees J. Infect. Dis. 141 1980 590 602
173. M. Rizzetto, B. Hoyer, M.G. Canese, J.W. Shih, R.H. Purcell, and J.L. Gerin Delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees Proc. Natl. Acad. Sci. U.S.A. 77 1980 6124 6128
174. H.D. Robertson How did replicating and coding RNAs first get together? Science 274 1996 66 67
175. M. Roggendorf Perspectives for a vaccine against hepatitis delta virus Semin. Liver Dis. 32 2012 256 261
176. R. Romeo, E. Del Ninno, M. Rumi, A. Russo, A. Sangiovanni, R. de Franchis, and et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma Gastroenterology 136 2009 1629 1638
177. R. Romeo, B. Foglieni, G. Casazza, M. Spreafico, M. Colombo, and D. Prati High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta PLoS One 9 2014 e92062
178. W.S. Ryu, M. Bayer, and J. Taylor Assembly of hepatitis delta virus particles J. Virol. 66 1992 2310 2315
179. W.S. Ryu, H.J. Netter, M. Bayer, and J. Taylor Ribonucleoprotein complexes of hepatitis delta virus J. Virol. 67 1993 3281 3287
180. E. Sagnelli, C. Sagnelli, M. Pisaturo, M. Macera, and N. Coppola Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy World J. Gastroenterol. 20 2014 7635 7643
181. K. Salehi-Ashtiani, A. Lupták, A. Litovchick, and J.W. Szostak A genomewide search for ribozymes reveals an HDV-like sequence in the human CPEB3 gene Science 313 2006 1788 1792
182. N. Saudy, F. Sugauchi, Y. Tanaka, S. Suzuki, A.A. Aal, M.A. Zaid, and et al. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt J. Med. Virol. 70 2003 529 536
183. M. Schaper, F. Rodriguez-Frias, R. Jardi, D. Tabernero, M. Homs, G. Ruiz, and et al. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D J. Hepatol. 52 2010 658 664
184. C. Scholtes, V. Icard, M. Amiri, P. Chevallier-Queyron, M.-A. Trabaud, C. Ramière, and et al. Standardized one-step real-time reverse transcription-PCR assay for universal detection and quantification of hepatitis delta virus from clinical samples in the presence of a heterologous internal-control RNA J. Clin. Microbiol. 50 2012 2126 2128
185. A. Schulze, P. Gripon, and S. Urban Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans Hepatology 46 2007 1759 1768
186. A. Schulze, A. Schieck, Y. Ni, W. Mier, and S. Urban Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction J. Virol. 84 2010 1989 2000
187. A. Serganov, and D.J. Patel Ribozymes, riboswitches and beyond: regulation of gene expression without proteins Nat. Rev. Genet. 8 2007 776 790
188. A. Servant-Delmas, F. Le Gal, P. Gallian, E. Gordien, and S. Laperche Increasing prevalence of HDV/HBV infection over 15 years in France J. Clin. Virol. 59 2014 126 128
189. L. Sharmeen, M.Y. Kuo, and J. Taylor Self-ligating RNA sequences on the antigenome of human hepatitis delta virus J. Virol. 63 1989 1428 1430
190. A. Smedile, J.L. Casey, P.J. Cote, M. Durazzo, B. Lavezzo, R.H. Purcell, and et al. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope Hepatology 27 1998 1723 1729
191. V. Soriano, E. Vispo, R. Sierra-Enguita, C. de Mendoza, J.V. Fernández-Montero, P. Labarga, and et al. Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients AIDS 28 2014 2389 2394
192. T. Stroffolini, P.L. Almasio, E. Sagnelli, A. Mele, and G.B. Gaeta Italian Hospitals' Collaborating Group. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study J. Med. Virol. 81 2009 1999 2006
193. C.-W. Su, Y.-H. Huang, T.-I. Huo, H.H. Shih, I.-J. Sheen, S.-W. Chen, and et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients Gastroenterology 130 2006 1625 1635
194. C. Sureau The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model Methods Mol. Biol. 640 2010 463 473
195. C. Sureau, and J. Salisse A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant Hepatology 57 2013 985 994
196. C. Sureau, J.R. Jacob, J.W. Eichberg, and R.E. Lanford Tissue culture system for infection with human hepatitis delta virus J. Virol. 65 1991 3443 3450
197. C. Sureau, B. Guerra, and R.E. Lanford Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion J. Virol. 67 1993 366 372
198. C. Sureau, B. Guerra, and H. Lee The middle hepatitis B virus envelope protein is not necessary for infectivity of hepatitis delta virus J. Virol. 68 1994 4063 4066
199. B.T. Sy, H.M. Nguyen, N.L. Toan, L.H. Song, H.V. Tong, C. Wolboldt, and et al. Identification of a natural intergenotypic recombinant hepatitis delta virus genotype 1 and 2 in Vietnamese HBsAg-positive patients J. Viral Hepatol. 22 2015 55 63
200. J.P. Tavanez, C. Cunha, M.C.A. Silva, E. David, J. Monjardino, and M. Carmo-Fonseca Hepatitis delta virus ribonucleoproteins shuttle between the nucleus and the cytoplasm RNA 8 2002 637 646
201. J.M. Taylor Chapter 3. Replication of the hepatitis delta virus RNA genome Adv. Virus Res. 74 2009 103 121
202. J.M. Taylor Virology of hepatitis D virus Semin. Liver Dis. 32 2012 195 200
203. J.M. Taylor Host RNA circles and the origin of hepatitis delta virus World J. Gastroenterol. 20 2014 2971 2978
204. J.M. Taylor, and Z. Han Purinergic receptor functionality is necessary for infection of human hepatocytes by hepatitis delta virus and hepatitis B virus PLoS One 5 2010 e15784
205. J. Taylor, and M. Pelchat Origin of hepatitis delta virus Future Microbiol. 5 2010 393 402
206. S. Urban, R. Bartenschlager, R. Kubitz, and F. Zoulim Strategies to inhibit entry of HBV and HDV into hepatocytes Gastroenterology 147 2014 48 64
207. E.R. Verrier, C.C. Colpitts, C. Bach, L. Heydmann, A. Weiss, M. Renaud, S.C. Durand, F. Habersetzer, D. Durantel, G. Abou-Jaoudé, M.M. López Ledesma, D.J. Felmlee, M. Soumillon, T. Croonenborghs, N. Pochet, M. Nassal, C. Schuster, L. Brino, C. Sureau, M.B. Zeisel, and T.F. Baumert A targeted functional RNAi screen uncovers Glypican 5 as an entry factor for hepatitis B and D viruses Hepatology 2015
208. U. Visco-Comandini, D. Lapa, C. Taibi, C. Angeletti, M.R. Capobianchi, and A.R. Garbuglia No impact of interleukin-28B polymorphisms on spontaneous or drug-induced hepatitis delta virus clearance Dig. Liver Dis. 46 2014 348 352
209. T. Volz, L. Allweiss, M. Ben MBarek, M. Warlich, A.W. Lohse, J.M. Pollok, and et al. The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus J. Hepatol. 58 2013 861 867
210. T.-C. Wang, and M. Chao RNA recombination of hepatitis delta virus in natural mixed-genotype infection and transfected cultured cells J. Virol. 79 2005 2221 2229
211. K.S. Wang, Q.L. Choo, A.J. Weiner, J.H. Ou, R.C. Najarian, R.M. Thayer, and et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome Nature 323 1986 508 514
212. M.L. Washburn, M.T. Bility, L. Zhang, G.I. Kovalev, A. Buntzman, J.A. Frelinger, and et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease Gastroenterology 140 2011 1334 1344
213. T. Watanabe, E.M. Sorensen, A. Naito, M. Schott, S. Kim, and P. Ahlquist Involvement of host cellular multivesicular body functions in hepatitis B virus budding Proc. Natl. Acad. Sci. U.S.A. 104 2007 10205 10210
214. K. Watashi, A. Sluder, T. Daito, S. Matsunaga, A. Ryo, S. Nagamori, and et al. Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) Hepatology 59 2014 1726 1737
215. C.-H.T. Webb, N.J. Riccitelli, D.J. Ruminski, and A. Lupták Widespread occurrence of self-cleaving ribozymes Science 326 2009 953
216. H. Wedemeyer, and M.P. Manns Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead Nat. Rev. Gastroenterol. Hepatol. 7 2010 31 40
217. H. Wedemeyer, B. Heidrich, and M.P. Manns Hepatitis D virus infection - not a vanishing disease in Europe! Hepatology 45 2007 1331 1332 author reply 1332-3
218. H. Wedemeyer, C. Yurdaydìn, G.N. Dalekos, A. Erhardt, Y. Çakaloʇlu, H. Deʇertekin, and et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta N. Engl. J. Med. 364 2011 322 331
219. H. Wedemeyer, C. Yurdaydin, S. Ernst, F.A. Caruntu, M.G. Curescu, K. Yalcin, and et al. Prolonged therapy of hepatitis delta for 96 weeks with pegylated-IFN-α-2a plus tenofovir or placebo does not prevent HDV-DNA relapse after tretament: the HIDIT-2 study J. Hepatol. 60 2014 S2 S3
220. C.Y. William Tong, R. Asher, M. Toby, S.L. Ngui, K. Tettmar, S. Ijaz, and et al. A re-assessment of the epidemiology and patient characteristics of hepatitis D virus infection in inner city London J. Infect. 66 2013 521 527
221. V. Williams, S. Brichler, N. Radjef, P. Lebon, A. Goffard, D. Hober, and et al. Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene J. Gen. Virol. 90 2009 2759 2767
222. V. Williams, S. Brichler, E. Khan, M. Chami, P. Dény, D. Kremsdorf, and et al. Large hepatitis delta antigen activates STAT-3 and NF-κB via oxidative stress J. Viral Hepatol. 19 Oct 2012 744 753
223. S.K. Wong, and D.W. Lazinski Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1 Proc. Natl. Acad. Sci. U.S.A. 99 2002 15118 15123
224. A. Wranke, B. Heidrich, S. Ernst, B. Calle Serrano, F.A. Caruntu, M.G. Curescu, and et al. Anti-HDV IgM as a marker of disease activity in hepatitis delta PLoS One 9 2014 e101002
225. H.N. Wu, Y.J. Lin, F.P. Lin, S. Makino, M.F. Chang, and M.M. Lai Human hepatitis delta virus RNA subfragments contain an autocleavage activity Proc. Natl. Acad. Sci. U.S.A. 86 1989 1831 1835
226. J.C. Wu, P.J. Chen, M.Y. Kuo, S.D. Lee, D.S. Chen, and L.P. Ting Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line J. Virol. 65 1991 1099 1104
227. J.C. Wu, T.Y. Chiang, W.K. Shiue, S.Y. Wang, I.J. Sheen, Y.H. Huang, and et al. Recombination of hepatitis D virus RNA sequences and its implications Mol. Biol. Evol. 16 1999 1622 1632
228. Y. Yamaguchi, J. Filipovska, K. Yano, A. Furuya, N. Inukai, T. Narita, and et al. Stimulation of RNA polymerase II elongation by hepatitis delta antigen Science 293 2001 124 127
229. T. Yamashiro, K. Nagayama, N. Enomoto, H. Watanabe, T. Miyagi, H. Nakasone, and et al. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction-and its possible correlation with the clinical stage of liver disease J. Infect. Dis. 189 2004 1151 1157
230. H. Yan, G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, and et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus eLife 2012 3
231. H. Yan, B. Peng, W. He, G. Zhong, Y. Qi, B. Ren, and et al. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide J. Virol. 87 2013 7977 7991
232. H. Yan, B. Peng, Y. Liu, G. Xu, W. He, B. Ren, and et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide J. Virol. 88 2014 3273 3284
233. E. Yilmaz, B. Baran, O.M. Soyer, M. Onel, D. Onel, A.C. Ormeci, and et al. Effects of polymorphisms in interferon λ 3 (interleukin 28B) on sustained virologic response to therapy in patients with chronic hepatitis D virus infection Clin. Gastroenterol. Hepatol. 12 2014 1753 1758
234. C. Yurdaydin Treatment of chronic delta hepatitis Semin. Liver Dis. 32 2012 237 244
235. C. YurdaydIn, R. Idilman, H. Bozkaya, and A.M. Bozdayi Natural history and treatment of chronic delta hepatitis J. Viral Hepat. 17 Nov 2010 749 756
236. M.B. Zeisel, J. Lucifora, W.S. Mason, C. Sureau, J. Beck, M. Levrero, and et al. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure Gut 2015